- WellCare Group (NYSE:WCG) initiated with Buy rating and $255 (26% upside) price target by Goldman Sachs (NYSE:GS).
- UnitedHealth Group (NYSE:UNH) initiated with Buy rating and $269 (22% upside) price target by Goldman.
- Humana (NYSE:HUM) initiated with Buy rating and $305 (21% upside) price target by Goldman.
- Centene (NYSE:CNC) initiated on the Conviction Buy List with a $135 (31% upside) price target by Goldman.
- Anthem (NYSE:ANTM) initiated with Neutral rating and $243 (8% upside) price target by Goldman.
- Universal Health Services (NYSE:UHS) initiated with Buy rating and $137 (18% upside) price target by Goldman.
- Tenet Healthcare (NYSE:THC) initiated with Neutral rating by Goldman.
- Molina Healthcare (NYSE:MOH) initiated with Neutral rating by Goldman.
- HCA Healthcare (NYSE:HCA) initiated with Neutral rating by Goldman.
- Cigna (NYSE:CI) initiated with Neutral rating by Goldman.
- LifePoint Health (NASDAQ:LPNT) initiated with Sell rating by Goldman.
- Community Health Systems (NYSE:CYH) initiated with Sell rating by Goldman.
- Savara (NASDAQ:SVRA) initiated with Buy rating and $35 (133% upside) price target by Ladenburg Thalmann.
- Now read: Implications Of UnitedHealth's Deal To Buy DaVita Unit
Original article